Patient Care
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cancer
November 27, 2017
Newspaper and prime time TV advertisements are beginning in the US today that detail the medical toll that smoking exacts on its victims. The ads are paid for by big tobacco based on a court order from 2006 that has finally survived the appeal process. A spokesperson for one of the companies stated that they hope to "develop less risky tobacco prod
November 20, 2017
This video shows a five-port technique for robot-assisted resection of hilar lung cancer.
November 17, 2017
Patient Care
November 15, 2017
The authors describe their technique for an S1+2 segmentectomy, discussing the anatomical landmarks and variations that are key in this procedure.
November 13, 2017
Filmed at the 2016 EACTS Annual Meeting in Barcelona, Spain, Leanne Harling of Imperial College in London, UK, moderates a discussion on the role of surgical therapy for N2 lung cancer.
November 9, 2017
Federico Venuta of the Sapienza University of Rome in Italy discusses surgical reconstruction techniques following resection of T4 lung cancer tumors.
November 8, 2017
This multicenter retrospective study sought to assess the utility of PET in the diagnosis of pulmonary nodules. It emphasized the inclusion of patient cohorts from different geographic regions and who underwent PET for different indications such as lung cancer screening or surgical evaluation. Among 1188 patients the positive predicted value was 86
October 31, 2017
In this single institution study, the prognostic role of soluble mesothelin-related peptides (SMRP) was evaluated in patients with pleural mesothelioma. Preoperative levels of SMRP were related to tumor volume and disease-free survival. Percent change in postoperative SMRP was predictive of tumor recurrence.
October 31, 2017
In this single institution study, the authors screened biorepository materials obtained from patients undergoing resection for early stage cancer. They wished to identify serum markers related to early recurrence. A 7-component panel was developed that had a negative predictive value of 83% and an accuracy of 78%. The accuracy was 70%.